Business

At Bitcoin 2025, Crypto Purists and the MAGA Faithful Collide

Now that Trump is in office, launching his own crypto ventures and asking for legislation establishing (light) digital asset regulations to appear on his desk by August, his supporters’ voices drown out those of the bitcoiners who warn how abandoning crypto’s principles could endanger their community. “Trying to [politicize bitcoin] is really dangerous for everybody,…

How the Loudest Voices in AI Went From ‘Regulate Us’ to ‘Unleash Us’

On May 16, 2023, Sam Altman appeared before a subcommittee of the Senate Judiciary. The title of the hearing was “Oversight of AI.” The session was a lovefest, with both Altman and the senators celebrating what Altman called AI’s “printing press moment”—and acknowledging that the US needed strong laws to avoid its pitfalls. “We think…

Businesses Got Squeezed by Trump’s Tariffs. Now Some of Them Want Their Money Back

As the chief merchandising officer for one of the largest sellers on Amazon, Owen Carr knew that the deck chairs he ordered from a Chinese factory in early April would cost him more than ever before. That’s because the chairs, which normally go for $79 on Amazon, were among the first Chinese imports subject to…

Freedom of the Press Foundation Threatens Legal Action if Paramount Settles With Trump Over ’60 Minutes’ Interview

Media advocacy group Freedom of the Press Foundation has sent a warning letter to Paramount mogul Shari Redstone, outlining plans to file a lawsuit if the media company settles a suit brought by President Donald Trump against its subsidiary, CBS. “Corporations that own news outlets should not be in the business of settling baseless lawsuits…

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

After telehealth startups recently lost the ability to sell exact copies of patented GLP-1 weight-loss drugs, some firms have begun turning to a different, less effective medication that has been on the market in the United States since 2010. Often considered a precursor to blockbuster products like Novo Nordisk’s Ozempic and Eli Lilly’s Zepbound, liraglutide…